429 related articles for article (PubMed ID: 9568062)
1. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP
Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169
[TBL] [Abstract][Full Text] [Related]
3. Antileukemic activity of synthetic daunomycinone derivatives bearing modifications in the glycosidic moiety.
Perchellet EM; Sperfslage BJ; McIlvain CJ; Aligiannis N; Pouli N; Marakos P; Skaltsounis AL; Perchellet JP
Anticancer Res; 2001; 21(6A):3957-67. PubMed ID: 11911277
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of novel tricyclic pyrone analogs in murine leukemia cells in vitro.
Perchellet JP; Newell SW; Ladesich JB; Perchellet EM; Chen Y; Hua DH; Kraft SL; Basaraba RJ; Omura S; Tomoda H
Anticancer Res; 1997; 17(4A):2427-34. PubMed ID: 9252658
[TBL] [Abstract][Full Text] [Related]
5. Tricyclic pyrone analogs: a new class of microtubule-disrupting anticancer drugs effective against murine leukemia cells in vitro.
Newell SW; Perchellet EM; Ladesich JB; Freeman JA; Chen Y; Liu L; Hua DH; Kraft SL; Basaraba RJ; Perchellet JP
Int J Oncol; 1998 Feb; 12(2):433-42. PubMed ID: 9458372
[TBL] [Abstract][Full Text] [Related]
6. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
[TBL] [Abstract][Full Text] [Related]
7. Triptycenes: a novel synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro.
Perchellet EM; Magill MJ; Huang X; Brantis CE; Hua DH; Perchellet JP
Anticancer Drugs; 1999 Sep; 10(8):749-66. PubMed ID: 10573208
[TBL] [Abstract][Full Text] [Related]
8. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
Bai R; Cichacz ZA; Herald CL; Pettit GR; Hamel E
Mol Pharmacol; 1993 Oct; 44(4):757-66. PubMed ID: 8232226
[TBL] [Abstract][Full Text] [Related]
9. The effects of alpha-methylene-gamma-lactone purines and pyrimidines on L1210 lymphoid leukemia nucleic acid metabolism.
Hall IH; Lee KH
Anticancer Res; 1991; 11(1):337-42. PubMed ID: 2018369
[TBL] [Abstract][Full Text] [Related]
10. 1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro.
Perchellet EM; Magill MJ; Huang X; Dalke DM; Hua DH; Perchellet JP
Anticancer Drugs; 2000 Jun; 11(5):339-52. PubMed ID: 10912950
[TBL] [Abstract][Full Text] [Related]
11. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity and mode of action of substituted indan-1, 3-diones in murine and human tissue cultured cells.
Hall IH; Wong OT; Chi LK; Chen SY
Anticancer Res; 1994; 14(5A):2053-8. PubMed ID: 7847849
[TBL] [Abstract][Full Text] [Related]
13. Bioactivity of synthetic 2-halo-3-aryl-4(3H)-quinazoliniminium halides in L1210 leukemia and SK-BR-3 mammary tumor cells in vitro.
Perchellet JP; Waters AM; Perchellet EM; Naganaboina VK; Chandra KL; Desper J; Rayat S
Anticancer Res; 2011 Jun; 31(6):2083-93. PubMed ID: 21737626
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro.
Jackson DV; Bender RA
Cancer Res; 1979 Nov; 39(11):4346-9. PubMed ID: 291476
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia cells in culture by sesquiterpene lactones.
Hall IH; Williams WL; Grippo AA; Lee KH; Holbrook DJ; Chaney SG
Anticancer Res; 1988; 8(1):33-42. PubMed ID: 2895992
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of tetra-mu-carboxylatodirhodium(II) in L1210 tumor suspension culture.
Howard RA; Kimball AP; Bear JL
Cancer Res; 1979 Jul; 39(7 Pt 1):2568-73. PubMed ID: 445459
[TBL] [Abstract][Full Text] [Related]
17. Quinone isomers of the WS-5995 antibiotics: synthetic antitumor agents that inhibit macromolecule synthesis, block nucleoside transport, induce DNA fragmentation, and decrease the growth and viability of L1210 leukemic cells more effectively than ellagic acid and genistein in vitro.
Perchellet EM; Sperfslage BJ; Qabaja G; Jones GB; Perchellet JP
Anticancer Drugs; 2001 Jun; 12(5):401-17. PubMed ID: 11395569
[TBL] [Abstract][Full Text] [Related]
18. DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues.
Hsiang YH; Liu LF; Wall ME; Wani MC; Nicholas AW; Manikumar G; Kirschenbaum S; Silber R; Potmesil M
Cancer Res; 1989 Aug; 49(16):4385-9. PubMed ID: 2545341
[TBL] [Abstract][Full Text] [Related]
19. Antitumor mechanisms of zinostatin stimalamer (YM881).
Tanaka S; Yamamoto M; Numasaki Y
Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):165-76. PubMed ID: 8774070
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of action of a novel macromolecular antitumor antibiotic, SN-07, on mouse leukemia L1210 cells in culture.
Yajima N; Miyata N; Kawanishi G; Katayama S; Tsukagoshi S
Jpn J Cancer Res; 1987 Oct; 78(10):1121-7. PubMed ID: 3119545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
